60 related articles for article (PubMed ID: 20813660)
1. [Protein kinase D3 is involved in negative regulation of MMP-7 in prostate cancer cells].
Zou ZP; Feng L; Xu WF; Ke ZY; Wang QJ; Deng F
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1767-70. PubMed ID: 20813660
[TBL] [Abstract][Full Text] [Related]
2. [PKD3 contributes to up-regulation of prostate-specific antigen in prostate cancer cells].
Deng F; Wang CX; Xu WF; Feng L; Ke ZY; Wang QJ; Zou ZP
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1779-82. PubMed ID: 20813663
[TBL] [Abstract][Full Text] [Related]
3. Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways.
Liu KC; Huang AC; Wu PP; Lin HY; Chueh FS; Yang JS; Lu CC; Chiang JH; Meng M; Chung JG
Oncol Rep; 2011 Jul; 26(1):177-84. PubMed ID: 21503582
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
[TBL] [Abstract][Full Text] [Related]
5. Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.
Cardillo MR; Di Silverio F; Gentile V
Anticancer Res; 2006; 26(2A):973-82. PubMed ID: 16619495
[TBL] [Abstract][Full Text] [Related]
6. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
Liu H; Chen A; Guo F; Yuan L
Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
[TBL] [Abstract][Full Text] [Related]
7. mRNA expression of the five membrane-type matrix metalloproteinases MT1-MT5 in human prostatic cell lines and their down-regulation in human malignant prostatic tissue.
Jung M; Römer A; Keyszer G; Lein M; Kristiansen G; Schnorr D; Loening SA; Jung K
Prostate; 2003 May; 55(2):89-98. PubMed ID: 12661033
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2.
Chen J; Deng F; Singh SV; Wang QJ
Cancer Res; 2008 May; 68(10):3844-53. PubMed ID: 18483269
[TBL] [Abstract][Full Text] [Related]
9. PCPH/ENTPD5 expression enhances the invasiveness of human prostate cancer cells by a protein kinase C delta-dependent mechanism.
Villar J; Arenas MI; MacCarthy CM; Blánquez MJ; Tirado OM; Notario V
Cancer Res; 2007 Nov; 67(22):10859-68. PubMed ID: 18006831
[TBL] [Abstract][Full Text] [Related]
10. Inducible silencing of protein kinase D3 inhibits secretion of tumor-promoting factors in prostate cancer.
LaValle CR; Zhang L; Xu S; Eiseman JL; Wang QJ
Mol Cancer Ther; 2012 Jul; 11(7):1389-99. PubMed ID: 22532599
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of urokinase plasminogen activator and matrix metalloproteinases and up-regulation of their inhibitors by a novel nutrient mixture in human prostate cancer cell lines PC-3 and DU-145.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2011 Dec; 26(6):1407-13. PubMed ID: 21874261
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of Id1 by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro.
Ling YX; Tao J; Fang SF; Hui Z; Fang QR
Eur J Cancer Prev; 2011 Jan; 20(1):9-17. PubMed ID: 20881502
[TBL] [Abstract][Full Text] [Related]
13. Individual C1 domains of PKD3 in phorbol ester-induced plasma membrane translocation of PKD3 in intact cells.
Anderson G; Chen J; Wang QJ
Cell Signal; 2005 Nov; 17(11):1397-411. PubMed ID: 15927450
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase D3 activation and phosphorylation by signaling through G alpha q.
Yuan J; Rey O; Rozengurt E
Biochem Biophys Res Commun; 2005 Sep; 335(2):270-6. PubMed ID: 16081049
[TBL] [Abstract][Full Text] [Related]
15. Involvement of matrix metalloproteinase-7 in invasion-metastasis through induction of cell dissociation in pancreatic cancer.
Tan X; Egami H; Ishikawa S; Sugita H; Kamohara H; Nakagawa M; Nozawa F; Abe M; Ogawa M
Int J Oncol; 2005 May; 26(5):1283-9. PubMed ID: 15809719
[TBL] [Abstract][Full Text] [Related]
16. Hyul-Tong-Ryung suppresses PMA-induced MMP-9 expression by inhibiting AP-1-mediated gene expression via ERK 1/2 signaling pathway in MCF-7 human breast cancer cells.
Kim KS; Yao L; Lee YC; Chung E; Kim KM; Kwak YJ; Kim SJ; Cui Z; Lee JH
Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):600-6. PubMed ID: 20131957
[TBL] [Abstract][Full Text] [Related]
17. Activation of protein kinase D3 by signaling through Rac and the alpha subunits of the heterotrimeric G proteins G12 and G13.
Yuan J; Rey O; Rozengurt E
Cell Signal; 2006 Jul; 18(7):1051-62. PubMed ID: 16198087
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP
Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938
[TBL] [Abstract][Full Text] [Related]
19. Regulation of matrix metalloproteinase 13 expression by androgen in prostate cancer.
Pang ST; Flores-Morales A; Skoog L; Chuan YC; Nordstedt G; Pousette A
Oncol Rep; 2004 Jun; 11(6):1187-92. PubMed ID: 15138554
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C-independent effects of protein kinase D3 in glucose transport in L6 myotubes.
Chen J; Lu G; Wang QJ
Mol Pharmacol; 2005 Jan; 67(1):152-62. PubMed ID: 15496505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]